Improving Access to Trikafta for Cystic Fibrosi...

By João L. Carapinha

December 16, 2024

The Competition Commission of South Africa recently published a media statement on cystic fibrosis medication access - Trikafta. This article highlights improvements in access to Trikafta, a critical medication for cystic fibrosis patients. Access...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.